Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability

NCT ID: NCT04363606

Last Updated: 2025-03-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

69 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-27

Study Completion Date

2022-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic fatigue is the most common and debilitating symptom in intensive care unit (ICU) survivors. Indeed, it has been widely reported that patients who stayed in ICU for prolonged periods report a feeling of tiredness for months to years after ICU discharge. This symptom seems particularly pronounced in Covid-19 patients and may affect their quality of life by decreasing their capacity to perform simple tasks of daily life.

The aim of the present project is to determine whether deteriorated neuromuscular function (i.e. increased fatigability) is involved in the feeling of fatigue of Covid-19 patients. Because the causes of this feeling are multi-dimensional, a large battery of tests will allow us to better understand the origin of chronic fatigue. A better knowledge of chronic fatigue etiology and its recovery will allow to optimize rehabilitation treatments to shorten the persistence of chronic fatigue and in fine improve life quality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Fatigue Syndrome Intensive Care Unit Muscle

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

"Non-fatigued" patients who have been in intensive care units

Group Type EXPERIMENTAL

Questionnaires

Intervention Type OTHER

Quality of life Depression Physical pain Social provisions Quality of sleep

blood test

Intervention Type BIOLOGICAL

complete blood count and cytokine concentration, TNF-alpha, LDL oxidized, AOPP, SOD, GPX, catalase, albumin, transthyretin, RBP, transferin, α-1 glycoprotein acide, ferritine, selenium, zinc, magnesium

Maximal effort test

Intervention Type OTHER

The maximal effort test with VO2max recordings will be assessed during the first visit to the laboratory.

actigraphy

Intervention Type DEVICE

assessment of sleep quality

Neuromuscular evaluation

Intervention Type DEVICE

* The maximum isometric force produced by the knee extensors will be measured on the ergometer
* the intensity of muscular electrical activity recorded by surface electromyography
* Peripheral nerve stimulation
* Transcranial magnetic stimulation
* Magnetic resonance imaging

stool analysis

Intervention Type OTHER

analyze the composition of the intestinal microbiote. concerns only the patients of Saint Etienne

food diary

Intervention Type OTHER

3 days of information to determine nutrient intakes. concerns only the patients of Saint Etienne

"Fatigued" patients who have been in intensive care units

Group Type EXPERIMENTAL

Questionnaires

Intervention Type OTHER

Quality of life Depression Physical pain Social provisions Quality of sleep

blood test

Intervention Type BIOLOGICAL

complete blood count and cytokine concentration, TNF-alpha, LDL oxidized, AOPP, SOD, GPX, catalase, albumin, transthyretin, RBP, transferin, α-1 glycoprotein acide, ferritine, selenium, zinc, magnesium

Maximal effort test

Intervention Type OTHER

The maximal effort test with VO2max recordings will be assessed during the first visit to the laboratory.

actigraphy

Intervention Type DEVICE

assessment of sleep quality

Neuromuscular evaluation

Intervention Type DEVICE

* The maximum isometric force produced by the knee extensors will be measured on the ergometer
* the intensity of muscular electrical activity recorded by surface electromyography
* Peripheral nerve stimulation
* Transcranial magnetic stimulation
* Magnetic resonance imaging

stool analysis

Intervention Type OTHER

analyze the composition of the intestinal microbiote. concerns only the patients of Saint Etienne

food diary

Intervention Type OTHER

3 days of information to determine nutrient intakes. concerns only the patients of Saint Etienne

patients who have not been in intensive care units

Group Type EXPERIMENTAL

Questionnaires

Intervention Type OTHER

Quality of life Depression Physical pain Social provisions Quality of sleep

blood test

Intervention Type BIOLOGICAL

complete blood count and cytokine concentration, TNF-alpha, LDL oxidized, AOPP, SOD, GPX, catalase, albumin, transthyretin, RBP, transferin, α-1 glycoprotein acide, ferritine, selenium, zinc, magnesium

Maximal effort test

Intervention Type OTHER

The maximal effort test with VO2max recordings will be assessed during the first visit to the laboratory.

actigraphy

Intervention Type DEVICE

assessment of sleep quality

Neuromuscular evaluation

Intervention Type DEVICE

* The maximum isometric force produced by the knee extensors will be measured on the ergometer
* the intensity of muscular electrical activity recorded by surface electromyography
* Peripheral nerve stimulation
* Transcranial magnetic stimulation
* Magnetic resonance imaging

stool analysis

Intervention Type OTHER

analyze the composition of the intestinal microbiote. concerns only the patients of Saint Etienne

food diary

Intervention Type OTHER

3 days of information to determine nutrient intakes. concerns only the patients of Saint Etienne

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires

Quality of life Depression Physical pain Social provisions Quality of sleep

Intervention Type OTHER

blood test

complete blood count and cytokine concentration, TNF-alpha, LDL oxidized, AOPP, SOD, GPX, catalase, albumin, transthyretin, RBP, transferin, α-1 glycoprotein acide, ferritine, selenium, zinc, magnesium

Intervention Type BIOLOGICAL

Maximal effort test

The maximal effort test with VO2max recordings will be assessed during the first visit to the laboratory.

Intervention Type OTHER

actigraphy

assessment of sleep quality

Intervention Type DEVICE

Neuromuscular evaluation

* The maximum isometric force produced by the knee extensors will be measured on the ergometer
* the intensity of muscular electrical activity recorded by surface electromyography
* Peripheral nerve stimulation
* Transcranial magnetic stimulation
* Magnetic resonance imaging

Intervention Type DEVICE

stool analysis

analyze the composition of the intestinal microbiote. concerns only the patients of Saint Etienne

Intervention Type OTHER

food diary

3 days of information to determine nutrient intakes. concerns only the patients of Saint Etienne

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with Covid-19
* Ventilated in ICU for at least 3 consecutive days
* ICU discharge between 4 and 8 weeks
* Approval received from a physician
* Command of the French language


* Diagnosed with Covid-19 : positive serological test or positive PCR test following nasopharyngeal swabbing
* Approval received from a physician
* Command of the French language

Exclusion Criteria

* Taking neuroactive substances that can alter corticospinal excitability
* Patients with co-morbidities leading to significant fatigue: e.g. cancerous pathologies, sleep apnea
* Patients with neurodegenerative or neuromuscular disease
* Contraindication to the application of a magnetic field
* Contraindication to the practice of Magnetic Resonance Imaging
* Participant is pregnant
* Patients with psychiatric disorders
* Paraplegic and hemiplegic patients
* Addictive disorders
Minimum Eligible Age

35 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Saint-Etienne

UNKNOWN

Sponsor Role collaborator

Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques

OTHER

Sponsor Role collaborator

Centre Hospitalier Universitaire de Saint Etienne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jérome MOREL, MD PhD

Role: PRINCIPAL_INVESTIGATOR

CHU de Saint Etienne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Grenoble

Grenoble, , France

Site Status

Clinique de la Sauvegarde - Lyon

Lyon, , France

Site Status

Hôpital Croix Rousse - HCL

Lyon, , France

Site Status

Centre Hospitalier de Lyon Sud

Pierre-Bénite, , France

Site Status

Hôpital privé de la Loire

Saint-Etienne, , France

Site Status

Chu Saint-Etienne

Saint-Etienne, , France

Site Status

Clinique Mutualiste Saint Etienne

Saint-Etienne, , France

Site Status

Hôpital Henry Gabrielle

Saint-Genis-Laval, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Kennouche D, Foschia C, Brownstein CG, Lapole T, Rimaud D, Royer N, LE Mat F, Thiery G, Gauthier V, Giraux P, Oujamaa L, Sorg M, Verges S, Doutreleau S, Marillier M, Prudent M, Bitker L, Feasson L, Gergele L, Stauffer E, Guichon C, Gondin J, Morel J, Millet GY. Factors Associated with Fatigue in COVID-19 ICU Survivors. Med Sci Sports Exerc. 2024 Sep 1;56(9):1563-1573. doi: 10.1249/MSS.0000000000003455. Epub 2024 Apr 14.

Reference Type DERIVED
PMID: 38742855 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20CH085

Identifier Type: -

Identifier Source: org_study_id

2020-A00982-37

Identifier Type: OTHER

Identifier Source: secondary_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

L-carnitine for Fatigue in COPD
NCT03008356 COMPLETED PHASE2/PHASE3
Ca-Mg Butyrate in GWI
NCT05367245 RECRUITING PHASE2
Creatine Supplementation in Chronic Fatigue Syndrome
NCT02374112 ACTIVE_NOT_RECRUITING NA
Eficacia Ventilatoria y Remolacha
NCT06217211 RECRUITING NA
NEUROmuscular Training for Enhanced AGE Longevity
NCT06620666 ACTIVE_NOT_RECRUITING NA